A critical review of the United States regulatory pathways for determining the equivalence of efficacy between CT-P13 and original infliximab (Remicade®).
| Autor: | Kim, Soohyun, Kim, Siun, Lee, Howard |
|---|---|
| Zdroj: | Drug Design, Development & Therapy; Jul2020, Vol. 14, p2831-2840, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|